Pakistan faces a critical shortage of over 100 essential medicines, including life-saving drugs. Delayed price revisions by the Drug Regulatory Authority of Pakistan are disrupting production. Rising costs of raw materials and currency depreciation have impacted manufacturing expenses significantly. This situation is creating space for counterfeit and substandard products in the market. Industry representatives urge the government to approve pending hardship pricing cases immediately.
Related Posts
Ambulance stuck in pothole for 2 hours, unborn baby dies in Agra
An unborn child died in Agra after an ambulance got stuck in a large pothole. The vehicle remained immobilized for…